Ginkgo Bioworks Shares Surge on Major Government Contract Win

Ginkgo Bioworks Holdings Registered (A) US37611X1000

Shares of Ginkgo Bioworks Holdings Registered (A) posted significant gains in Friday’s trading session. The catalyst was the announcement of a substantial new government contract, providing the biotechnology firm with long-term revenue visibility and strategic stability.

Investors responded positively to the news, driving the stock price up by 6 percent to $9.76. The surge reflects renewed confidence in the company’s strategic direction following the contract award.

The cell programming and biosecurity company has been awarded a contract worth up to $47 million by the Environmental Molecular Sciences Laboratory (EMSL). This agreement is structured as a four-year engagement, ensuring a predictable income source for Ginkgo Bioworks over the medium term.